Phan Tuấn Đạt: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Phạm Mạnh Hùng: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Nguyễn Lân Việt: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
1. Benjamin,E.J.,etal., HeartDiseaseandStrokeStatistics-2019Update:AReportFromtheAmericanHeartAssociation. Circulation, 2019. 139(10): p. e56-e528.
2.
2. Wollert, K.C., et al., Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 2004. 364(9429): p. 141-8.
Effectsofintracoronaryinjectionofmononuclearbonemarrowcellsonleftventricularfunction,arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J, 2008. 29(22): p. 2723-32.
5. Abdel-Latif, A., et al., Adult bone marrow-derived cells for cardiac repair: a systematic review and meta- analysis. Arch Intern Med, 2007. 167(10): p. 989-97.
8. Liu,Y.,etal., Impairedcardioprotectivefunctionoftransplantationofmesenchymalstemcellsfrompatients with diabetes mellitus to rats with experimentally induced myocardial infarction. Cardiovasc Diabetol, 2013. 12: p. 40.
9. Lamirault, G., et al., Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial. Stem Cell Res Ther, 2013. 4(6): p. 152.